Palak Shah, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Natera(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Ortho Clinical Diagnostics(SIGNIFICANT), Tosoh Biosciences(SIGNIFICANT), JVP Labs(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Procyrion(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Abbott Laboratories(SIGNIFICANT)

View Full Disclosure